News & Events

  • SMAHRT Research Staff Receive UW Madison Holtz Center Travel Grant

    Aubrey Gower
    Aubrey Gower
    Marina Jenkins
    Marina C. Jenkins

    Congratulations to SMAHRT research staff Aubrey Gower and Marina Jenkins, who have received a grant from the Robert E. and Jean F. Holtz Center for Science and Technology Studies to attend the 2018 annual meeting of the Society for Adolescent Health and Medicine. Aubrey and Marina, members of the Social Media and Adolescent Health Research Team lead by Dr. Megan Moreno, will be presenting their work at the March meeting in Seattle.

     
  • Dr. David Allen awarded 2018 Kaplowitz Endowed Lectureship for Quality Care

    David Allen, MD
    David Allen, MD

    Congratulations to David B. Allen, MD, who has been awarded the 2018 American Academy of Pediatrics/Pediatric Endocrine Society Kaplowitz Endowed Lectureship for Quality Care. This national award is given annually to recognize career contributions to quality and cost-effective care in Pediatric Endocrinology. Dr. Allen will present his Kaplowitz Lecture entitled “Growth-promoting treatment: Discretion is the better part of value” in May at this year’s meeting of the Pediatric Academic Societies in Toronto, Canada.

     
  • Dr. Dipesh Navsaria Receives Wisconsin Academy Fellows Award

    Posted: January 2018
    Dipesh Navsaria, MPH, MSLIS, MD
    Dipesh Navsaria, MPH,
    MSLIS, MD

    The Wisconsin Academy of Sciences, Arts & Letters today announced Dipesh Navsaria, MPH, MSLIS, MD, as one of fourteen recipients of the 2018 Academy Fellows Award, making him the first pediatrician to be named a Wisconsin Academy Fellow. Established by the Academy in 1982, the Wisconsin Academy Fellows Award recognizes educators, researchers, mentors, artists, and civic or business leaders from across Wisconsin who have made substantial contributions to the cultural life and welfare of our state and its people. The winners will be given their awards at an April 6, 2018, celebration hosted by the Wisconsin Academy at the Pyle Center at UW–Madison. The award celebration is open to the public with advance registration at wisconsinacademy.org/2018FellowsAwards.

     
  • Dr. Sharon Bartosh Named Editor-in-Chief of Pediatric Transplantation

    Posted: January 2018
    Sharon Bartosh, MD
    Sharon Bartosh, MD

    Congratulations to Sharon Bartosh, MD, a professor (CHS) and chief of the Division of Nephrology, for being named an editor-in-chief of the journal Pediatric Transplantation

    Dr. Bartosh, along with co-editor-in-chief Burkhard Tönshoff, MD, PhD, a professor of pediatrics at University Children's Hospital in Heidelberg, Germany, began her position on January 1, 2018. 

    Pediatric Transplantation is the official publication of the International Pediatric Transplant Association (IPTA), an international society of pediatric transplant health professionals across five continents and 56 countries.

    Congratulations, Dr. Bartosh, on this honor!

     
  • HuiChuan Lai, PhD, RD, and Phil Farrell, MD, PhD, Receive Grant from Cystic Fibrosis Foundation Therapeutics

    Congratulations to HuiChuan Lai, PhD, RD, Principal Investigator, and Phil Farrell, MD, PhD, Co-Principal Investigator, along with Co-Investigator Michael Rock, MD, who were recently awarded a 3-year grant from Cystic Fibrosis Foundation Therapeutics, Inc. in the amount of $1,092,063. This Clinical Research Award, entitled, "Impact of Early Malnutrition on Lung Disease Development in Cystic Fibrosis," will build on the success of her Feeding Infants Right... from the STart (FIRST) study, with expansion to 1) add chest CT and lung clearance index (LCI) assessments at 5-6 years of age and, 2) modernize biological specimen management, and 3) link the FIRST study cohort to the Cystic Fibrosis Foundation (CFF) patient registry for future, long-term outcome studies. This multi-center clinical study involves 5 CF Centers in 4 states (Utah, Wisconsin, Indiana, and Massachusetts).

     
  • HuiChuan Lai, PhD, RD, Receives NIH Supplement

    HuiChuan Lai, PhD, RD, was awarded a 1-year supplement in the amount of $153,000 from the Office of the Director and the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (NIDDK-NIH) to her R01 Research Grant. This Research Supplement, entitled, "Probiotic Use, Intestinal Inflammation and Gut Microbiome in Young Children with Cystic Fibrosis," has as its overall objective to determine the prevalence of probiotic supplementation and its potential benefits on reducing intestinal inflammation and modifying gut microbiome in children with Cystic Fibrosis younger than 2 years of age. Congratulations!

     
  • David McCulley, MD, Awarded ICTR Pilot Grant

    David McCulley, MD
    David McCulley, MD

    David McCulley, MD, Principal Investigator, along with Shaoqin Gong, PhD, and Naomi Chesler, PhD, UW College of Engineering, were recently awarded a $50,000 pilot grant from the UW Institute for Clinical and Translational Research (ICTR). In their one-year project, entitled "Targeted Treatment for Pulmonary Hypertension Associated with Congenital Diaphragmatic Hernia," they plan to develop and test a novel drug targeting approach utilizing the foundation of direct patient care experience and improved understanding of the genetic and molecular basis of pulmonary hypertension. The central hypothesis is that microparticle-targeted delivery of agents, such as Y-27632, to the dysfunctional pulmonary vascular smooth cells, will improve their therapeutic benefit and reduce pulmonary hypertension, while minimizing systemic side effects in infants with congenital diaphragmatic hernia (CDH). Infants with CDH often do not survive after birth due to abnormal development of the lungs and pulmonary vasculature causing lethal pulmonary hypoplasia and pulmonary hypertension.

     
  • Luke Lamers, MD, Awarded ICTR Pilot Grant

    Luke Lamers, MD
    Luke Lamers, MD

    Congratulations to Luke Lamers, MD, who was recently awarded $50,000 for his research grant entitled, "Assessment of Early vs. Delayed Catheter Intervention for Management of Pulmonary Artery Stenosis." In this one-year grant from the UW Institute for Clinical and Translational Research (ICTR), Dr. Lamers will utilize a pig model to generate detailed data regarding the common clinical problem of pulmonary artery (PA) stenosis, in order to inform better decisions about timing of surgical intervention in treatment of congenital heart disease.

     
  • Marcel Wüthrich, PhD, Awarded NIH R01 Renewal Funding

    Marcel Wüthrich, PhD
    Marcel Wüthrich, PhD

    Congratulations to Principal Investigator Marcel Wüthrich, PhD, on his recent R01 award of over $2.2 million for his grant, "Regulation of vaccine-induced anti-fungal Th17 cells," from the National Institutes of Health - National Institute of Allergy and Infectious Diseases (NIH-NIAID). This 4-year renewal, in collaboration with Bruce Klein, MD, Co-Investigator, provides funding for Years 6-9 of this project, which will investigate a novel adjuvant that elicits cellular immune responses needed for better vaccines. The lack of an appropriate adjuvant is one major barrier to developing a safe and effective vaccine against infections with fungal pathogens, which represents an unmet need in medicine and public health.

     
  • Phil Farrell, MD, PhD, and Mei Baker, MD, Awarded Grant from The Legacy of Angels Foundation

    Phil Farrell, MD, PhD
    Phil Farrell, MD, PhD
    Mei Baker, MD
    Mei Baker, MD

    Phil Farrell, MD, PhD, Principal Investigator, and Mei Baker, MD, Co-Principal Investigator, were recently awarded a 3-year grant in the amount of $717,045 for the grant entitled, "Assessing the Added Value of Whole Genome Sequencing in Cystic Fibrosis Newborn Screening." This grant from The Legacy of Angels Foundation provides additional funding to complement research done in Dr. HuiChuan Lai's FIRST study supported by NIH and Cystific Fibrosis Foundation (CFF) to add whole genome sequencing (WGS) assessment. We anticipate that the WGS data will help explain the onset and course of cystic fibrosis (CF) to aid clinical decision making in the care of children with CF.